| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 27550-64-7 | Acetamide,N-[3-[[2-(2,5-dioxo-1-pyrrolidinyl)ethyl]ethylamino]phenyl]-; Acetanilide,3'-[ethyl(2-succinimidoethyl)amino]- (8CI); N-Ethyl-N-b-succinimidoethyl-m-acetamidoaniline |  | C16H21N3O3 | 詳情 | 供應商 | |
| 62549-92-2 | Carbamicacid, [2-amino-1-(1H-indol-3-ylmethyl)-2-oxoethyl]-, 1,1-dimethylethyl ester,(S)- (9CI); (S)-N-(1-(Carbamoyl)-2-(1H-indol-3-yl)ethyl)carbamicacid tert-butyl ester |  | C16H21N3O3 | 詳情 | 供應商 | |
| 24587-37-9 | L-Tryptophan, L-valyl-; L-Tryptophan,N-L-valyl-; Tryptophan, N-L-valyl-, L- (8CI); 117: PN: WO2006024694 SEQID: 117claimed protein; L-Valyl-L-tryptophan; Valyltryptophan |  | C16H21N3O3 | 詳情 | 供應商 | |
| 17929-68-9 | L-Lysine,N6-[2-(1H-indol-3-yl)acetyl]-; L-Lysine,N6-(1H-indol-3-ylacetyl)- (9CI); Lysine, N6-(indol-3-ylacetyl)-, L- (8CI); 3-Indoleacetyl-e-L-lysine; Indole-3-aceto-e-L-lysine; Indole-3-acetyl-Ne-L-lysine |  | C16H21N3O3 | 詳情 | 供應商 | |
| 24613-12-5 | L-Valine, L-tryptophyl-; L-Valine,N-L-tryptophyl-; Valine, N-L-tryptophyl-, L- (8CI); 2053: PN: EP2071334 SEQID:2163 claimed protein; 2053: PN: WO2009077864 SEQID: 2163 claimed protein; 5:PN: EP2161028 PAGE: 10 claimed protein; L-Tryptophyl-L-valine |  | C16H21N3O3 | 詳情 | 供應商 | |
| 92605-76-0 | Hexanamide,2,6-diamino-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-, (2S)-; Hexanamide,2,6-diamino-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-, (S)-; L-Lysine4-methylcoumaryl-7-amide |  | C16H21N3O3 | 詳情 | 供應商 | |
| 16875-60-8 | Pentanoic acid,4-amino-5-[[2-(1H-indol-3-yl)-1-methylethyl]amino]-5-oxo-; Glutaramicacid, 4-amino-N-(2-indol-3-yl-1-methylethyl)- (8CI); L-a-Glutamyl-a-methyltryptamine |  | C16H21N3O3 | 詳情 | 供應商 | |
| 12672-63-8 | Pentanoic acid,4-amino-5-[[(1R)-2-(1H-indol-3-yl)-1-methylethyl]amino]-5-oxo-, (4S)-; Pentanoicacid, 4-amino-5-[[2-(1H-indol-3-yl)-1-methylethyl]amino]-5-oxo-, [R-(R*,S*)]-; Glutramine |  | C16H21N3O3 | 詳情 | 供應商 | |
| 28837-79-8 | 1H-Indole-2-carboxamide,N-[3-(dimethylamino)propyl]-3-formyl-5-methoxy-; Indole-2-carboxamide,N-[3-(dimethylamino)propyl]-3-formyl-5-methoxy- (8CI) |  | C16H21N3O3 | 詳情 | 供應商 | |
| 83929-35-5 | 1,3,8-Triazaspiro[4.5]decane-8-carboxylicacid, 4-oxo-1-phenyl-, ethyl ester; ethyl 4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carboxylate |  | C16H21N3O3 | 詳情 | 供應商 | |
| 195390-64-8 | 1-Piperazinecarboxylicacid, 4-(2-benzoxazolyl)-, 1,1-dimethylethyl ester |  | C16H21N3O3 | 詳情 | 供應商 | |
| 81215-73-8 | 1H-[1,2,5]Triazepino[1,2-b]phthalazine-1,5(2H)-dione,3,4,7,12-tetrahydro-3-(3-methoxypropyl)-; NSC 340349 |  | C16H21N3O3 | 詳情 | 供應商 | |
| 3038-25-3 | 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[4-(diethylamino)phenyl]-5-ethyl-; Barbituricacid, 5-[p-(diethylamino)phenyl]-5-ethyl- (7CI,8CI); 5-[4-(Diethylamino)phenyl]-5-ethylbarbituricacid |  | C16H21N3O3 | 詳情 | 供應商 | |
| 135779-82-7 | 2(1H)-Quinoxalinone,3-[3-[[(methylamino)carbonyl]oxy]propyl]-1-propyl-; Bamaquimast; Baquimast |  | C16H21N3O3 | 詳情 | 供應商 | |
| 105891-75-6 | 2,4(3H,5H)-Pyrimidinedione,5,5-diethyl-6-[[2-(4-hydroxyphenyl)ethyl]amino]- |  | C16H21N3O3 | 詳情 | 供應商 | |
| 251451-30-6 | 2-Oxazolidinone,4-[[3-[2-(dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-; (4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinon; Zolmitriptan N-Oxide; (4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone |  | C16H21N3O3 | 詳情 | 供應商 | |
| 64377-91-9 | 2(1H)-Phthalazinebutanamide,3,4-dihydro-3-methyl-N-(1-methylethyl)-1,4-dioxo-; NSC 267971 |  | C16H21N3O3 | 詳情 | 供應商 | |
| 105783-16-2 | 3-Pyridinecarboxylicacid,2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-5-propyl- |  | C16H21N3O3 | 詳情 | 供應商 | |